Abstract

Keywords: iron overload; chelation therapy; non-transfusion-dependent thalassaemia; liver iron concentration; serum ferritin

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Serum ferritin values between 300 and 800 ng/mL in nontransfusion-dependent thalassemia: A probability curve to guide clinical decision making when MRI is unavailable.
Shahina Daar ... Giovanna Graziadei
American journal of hematology | VOL. 92
Shahina Daar, et. al.Shahina Daar ... Giovanna Graziadei
01 Feb 2017
Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias.
Farrukh T Shah ... Shivan Pancham
British journal of haematology | VOL. 196
Farrukh T Shah, et. al.Farrukh T Shah ... Shivan Pancham
06 Oct 2021
Iron chelation therapy for patients with sickle cell disease and iron overload
Ali T Taher ... Evelyne Khoriaty
American Journal of Hematology | VOL. 85
Ali T Taher, et. al.Ali T Taher ... Evelyne Khoriaty
29 Jun 2010
Clinical-Pathological Features of Non-Transfusion Dependent Thalassemia in Adults — a Single Center Study in Hong Kong
Natalie P H Chan ... Carmen K M Ng
Blood | VOL. 132
Natalie P H Chan, et. al.Natalie P H Chan ... Carmen K M Ng
29 Nov 2018
View more papers

More From: British journal of haematology

Paper Title
Journal
Date
Author
Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I-BFM Study Group.
Herbert Pichler ... Adriana Balduzzi
British journal of haematology | VOL. -
Herbert Pichler, et. al.Herbert Pichler ... Adriana Balduzzi
27 May 2024
Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre-autologous stem cell transplant in relapsed/refractory diffuse large B-cell lymphoma-outcome of rituximab-dose-intensive cyclophosphamide, etoposide, cisplatin (R-DICEP) versus R-GDP.
Douglas A Stewart ... Michael Crump
British journal of haematology | VOL. -
Douglas A Stewart, et. al.Douglas A Stewart ... Michael Crump
27 May 2024
RUNX1::ETO and CBFβ::MYH11 converge on aberrant activation of BCAT1 to confer a therapeutic vulnerability in core-binding factor-acute myeloid leukaemia.
Siyang Wang ... Kankan Wang
British journal of haematology | VOL. -
Siyang Wang, et. al.Siyang Wang ... Kankan Wang
27 May 2024
Assessment of fatigue in adult patients with sickle cell disease: Useof the functional assessment of chronic illness therapy-Fatigue (FACIT-fatigue) questionnaire.
Geoffrey Cheminet ... Jean‐Benoît Arlet
British journal of haematology | VOL. -
Geoffrey Cheminet, et. al.Geoffrey Cheminet ... Jean‐Benoît Arlet
27 May 2024
View more papers